Skip to main content

Privium Fund Management B.V.

13F filer · CIK 0001795097
Reported Aug 7, 2026
Net seller this quarter
13F portfolio value$544MU.S. long equity reported on 13F
Positions6110 new · 8 closed
Net flow last quarter-$16.8MBuys minus sells
Top 10 positions weight61.8%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 7, 202661 positions
TSLATesla, Inc.$95.9M17.62%0.01%+2.7%Q2 2022
SHOPShopify Inc.$42.2M7.76%0.09%-9.1%Q4 2021
AMDAdvanced Micro Devices Inc$36M6.62%0.00%Not reportedQ3 2022
AMZNAmazon Com Inc$33.4M6.13%0.00%+12.0%Q3 2022
IONSIonis Pharmaceuticals Inc$25.4M4.66%0.19%+10.3%Q4 2021
SPOTSpotify Technology S.A.$25.3M4.64%0.03%-17.9%Q4 2021
PLTRPalantir Technologies Inc.$23.3M4.29%0.01%Not reportedQ4 2021
ARWRArrowhead Pharmaceuticals, Inc.$19.1M3.51%0.17%-36.2%Q4 2021
OPENOpendoor Technologies Inc.$18.2M3.35%0.41%NewQ2 2026
LMNDLemonade, Inc.$17.6M3.23%0.35%+5.9%Q1 2023
NVDANvidia Corp$16.2M2.98%0.00%Not reportedQ2 2022
IRENIREN Ltd$15.6M2.86%0.10%+6.3%Q3 2025
QUREuniQure N.V.$15.1M2.78%0.47%-32.5%Q4 2021
CBRSCerebras Systems Inc.$13.4M2.46%Not reportedNewQ2 2026
ASTSAST SpaceMobile, Inc.$12.9M2.37%Not reportedNot reportedQ3 2024
RAREUltragenyx Pharmaceutical Inc.$11.3M2.08%0.34%-7.1%Q4 2021
ARQTArcutis Biotherapeutics, Inc.$10.5M1.92%0.32%+24.4%Q4 2024
BIIBBiogen Inc.$10.5M1.92%0.03%+10.5%Q1 2022
PRQRProQR Therapeutics N.V.$10.3M1.89%5.24%+1.0%Q4 2021
AXSMAxsome Therapeutics, Inc.$9.78M1.80%0.08%-32.0%Q1 2023
URGNUroGen Pharma Ltd.$7.73M1.42%0.43%-11.8%Q4 2024
SPCXSpace Exploration Technologies Corp$6.83M1.26%Not reportedNewQ2 2026
DNLIDenali Therapeutics Inc.$5.91M1.09%0.14%-9.8%Q1 2026
VRTXVertex Pharmaceuticals Inc / Ma$4.67M0.86%0.00%-17.2%Q4 2021
BMRNBiomarin Pharmaceutical Inc$4.29M0.79%0.04%-18.8%Q1 2026
KRYSKrystal Biotech, Inc.$4.15M0.76%0.04%Not reportedQ1 2022
ALNYAlnylam Pharmaceuticals, Inc.$3.42M0.63%0.01%-7.0%Q4 2021
VRDNViridian Therapeutics, Inc.\DE$3.19M0.59%0.15%Not reportedQ4 2025
BNTXBioNTech SE$2.8M0.51%0.01%+11.5%Q2 2025
HIMSHims & Hers Health, Inc.$2.77M0.51%Not reported+100.0%Q2 2025
MGTXMeiraGTx Holdings plc$2.65M0.49%0.21%-7.5%Q1 2024
ABEVAmbev S.A.$2.52M0.46%0.01%-15.4%Q1 2022
SRPTSarepta Therapeutics, Inc.$2.45M0.45%0.13%+196.7%Q2 2025
CRSPCRISPR Therapeutics AG$2.45M0.45%0.05%+4.9%Q1 2022
BEAMBeam Therapeutics Inc.$2.41M0.44%0.07%+9.9%Q3 2025
ZLABZai Lab Ltd$2.32M0.43%0.01%-7.6%Q4 2021
MRNAModerna, Inc.$2.1M0.39%0.01%Not reportedQ1 2022
RNACCartesian Therapeutics, Inc.$1.58M0.29%0.50%-15.3%Q4 2025
MICCMagnum Ice Cream Co N.V.$1.5M0.27%0.02%NewQ2 2026
WVEWave Life Sciences, Inc.$1.4M0.26%0.12%Not reportedQ3 2024
TSHATaysha Gene Therapies, Inc.$1.35M0.25%0.06%+9.4%Q2 2024
ZTSZoetis Inc.$1.24M0.23%0.00%NewQ2 2026
FDMT4D Molecular Therapeutics, Inc.$1.2M0.22%0.16%-47.1%Q3 2023
FATEFate Therapeutics Inc$1.12M0.21%0.36%Not reportedQ3 2024
LEGNLegend Biotech Corp$1.02M0.19%0.01%NewQ2 2026
RCKTRocket Pharmaceuticals, Inc.$835K0.15%0.22%+0.8%Q2 2022
NOVNOV Inc.$780K0.14%0.01%Not reportedQ4 2021
BTGB2gold Corp$730K0.13%0.01%+102.2%Q4 2021
TTETotalEnergies SE$729K0.13%0.00%NewQ2 2026
LXEOLexeo Therapeutics, Inc.$722K0.13%0.20%-24.4%Q4 2024
Q1 2026Reported May 5, 202659 positions
TSLATesla, Inc.$82.5M17.18%0.01%-2.8%Q2 2022
SHOPShopify Inc.$48.3M10.05%0.10%-0.7%Q4 2021
SPOTSpotify Technology S.A.$32.5M6.76%0.03%-1.5%Q4 2021
PLTRPalantir Technologies Inc.$29.3M6.09%0.01%Not reportedQ4 2021
AMZNAmazon Com Inc$26M5.42%0.00%+3.3%Q3 2022
ARWRArrowhead Pharmaceuticals, Inc.$23M4.79%0.26%-7.9%Q4 2021
IONSIonis Pharmaceuticals Inc$21.8M4.53%0.17%+20.4%Q4 2021
LMNDLemonade, Inc.$16M3.33%0.33%+2.8%Q1 2023
NVDANvidia Corp$14.1M2.94%0.00%Not reportedQ2 2022
COINCoinbase Global, Inc.$13.8M2.87%0.03%Not reportedQ4 2021
AMDAdvanced Micro Devices Inc$12.6M2.63%0.00%+3.3%Q3 2022
ASTSAST SpaceMobile, Inc.$12M2.50%Not reportedNot reportedQ3 2024
SESea Ltd$11.4M2.38%0.08%Not reportedQ4 2021
IRENIREN Ltd$11M2.28%0.10%+14.3%Q3 2025
AXSMAxsome Therapeutics, Inc.$9.93M2.07%0.11%+3.3%Q1 2023
ESPREsperion Therapeutics, Inc.$9.04M1.88%1.28%NewQ1 2026
PRQRProQR Therapeutics N.V.$8.86M1.84%5.19%+2.0%Q4 2021
BIIBBiogen Inc.$8.03M1.67%0.03%-40.4%Q1 2022
QUREuniQure N.V.$7.95M1.66%0.77%+16.9%Q4 2021
RAREUltragenyx Pharmaceutical Inc.$7.64M1.59%0.37%+2.0%Q4 2021
ARQTArcutis Biotherapeutics, Inc.$7.56M1.57%0.26%+4.9%Q4 2024
BMRNBiomarin Pharmaceutical Inc$5.21M1.09%0.05%NewQ1 2026
VRTXVertex Pharmaceuticals Inc / Ma$5.07M1.06%0.00%+21.4%Q4 2021
DNLIDenali Therapeutics Inc.$4.89M1.02%0.16%NewQ1 2026
URGNUroGen Pharma Ltd.$4.28M0.89%0.49%+11.0%Q4 2024
ALNYAlnylam Pharmaceuticals, Inc.$4.04M0.84%0.01%Not reportedQ4 2021
VRDNViridian Therapeutics, Inc.\DE$3.39M0.71%0.17%Not reportedQ4 2025
KRYSKrystal Biotech, Inc.$2.89M0.60%0.04%-8.2%Q1 2022
ABEVAmbev S.A.$2.77M0.58%0.01%-10.8%Q1 2022
ZLABZai Lab Ltd$2.49M0.52%0.01%Not reportedQ4 2021
BNTXBioNTech SE$2.4M0.50%0.01%-18.9%Q2 2025
ENGNenGene Therapeutics Inc.$2.4M0.50%0.53%Not reportedQ4 2025
CRSPCRISPR Therapeutics AG$2.04M0.42%0.04%Not reportedQ1 2022
MGTXMeiraGTx Holdings plc$1.84M0.38%0.26%+6.1%Q1 2024
WVEWave Life Sciences, Inc.$1.75M0.36%0.13%+24.9%Q3 2024
STOKStoke Therapeutics, Inc.$1.63M0.34%0.08%-9.1%Q4 2025
FDMT4D Molecular Therapeutics, Inc.$1.59M0.33%0.33%-18.9%Q3 2023
BEAMBeam Therapeutics Inc.$1.52M0.32%0.06%-10.5%Q3 2025
MRNAModerna, Inc.$1.52M0.32%0.01%-39.5%Q1 2022
PFEPfizer Inc$1.48M0.31%0.00%+39.6%Q1 2023
LXEOLexeo Therapeutics, Inc.$1.18M0.24%0.28%+6.5%Q4 2024
RNACCartesian Therapeutics, Inc.$1.1M0.23%0.63%+3.8%Q4 2025
MOHMolina Healthcare, Inc.$1.09M0.23%0.02%NewQ1 2026
SRPTSarepta Therapeutics, Inc.$1M0.21%0.04%+7.0%Q2 2025
SLBSLB Limited$948K0.20%0.00%-52.5%Q4 2021
RCKTRocket Pharmaceuticals, Inc.$867K0.18%0.22%+42.3%Q2 2022
HIMSHims & Hers Health, Inc.$830K0.17%Not reportedNot reportedQ2 2025
TSHATaysha Gene Therapies, Inc.$813K0.17%0.06%+10.3%Q2 2024
NOVNOV Inc.$791K0.16%0.01%-20.9%Q4 2021
RIGTransocean Ltd.$707K0.15%0.01%-23.6%Q3 2025
Q4 2025Reported Feb 3, 202656 positions
TSLATesla, Inc.$103M18.92%0.01%-6.4%Q2 2022
SHOPShopify Inc.$66M12.15%0.10%-1.2%Q4 2021
SPOTSpotify Technology S.A.$39.5M7.27%0.03%-28.4%Q4 2021
PLTRPalantir Technologies Inc.$35.6M6.55%0.01%Not reportedQ4 2021
AMZNAmazon Com Inc$27.9M5.14%0.00%-18.8%Q3 2022
ARWRArrowhead Pharmaceuticals, Inc.$26.4M4.87%0.29%-16.0%Q4 2021
IONSIonis Pharmaceuticals Inc$19.1M3.51%0.15%-3.2%Q4 2021
COINCoinbase Global, Inc.$17.9M3.29%0.03%Not reportedQ4 2021
LMNDLemonade, Inc.$17.7M3.25%0.33%+71.2%Q1 2023
SESea Ltd$17.6M3.24%0.08%-13.8%Q4 2021
NVDANvidia Corp$15.1M2.78%0.00%Not reportedQ2 2022
BIIBBiogen Inc.$12.9M2.38%0.05%+41.5%Q1 2022
AMDAdvanced Micro Devices Inc$12.8M2.37%0.00%Not reportedQ3 2022
PRQRProQR Therapeutics N.V.$10.8M1.99%5.09%+7.2%Q4 2021
IRENIREN Ltd$10.6M1.95%0.10%+115.4%Q3 2025
ASTSAST SpaceMobile, Inc.$10.5M1.94%Not reported+31.8%Q3 2024
AXSMAxsome Therapeutics, Inc.$10.4M1.91%0.11%+7.9%Q1 2023
QUREuniQure N.V.$9.96M1.83%0.67%+7.8%Q4 2021
ARQTArcutis Biotherapeutics, Inc.$8.89M1.64%0.25%Not reportedQ4 2024
RAREUltragenyx Pharmaceutical Inc.$8.22M1.51%0.37%+23.4%Q4 2021
VRDNViridian Therapeutics, Inc.\DE$5.4M0.99%0.17%NewQ4 2025
URGNUroGen Pharma Ltd.$5.03M0.93%0.44%+9.2%Q4 2024
VRTXVertex Pharmaceuticals Inc / Ma$4.24M0.78%0.00%+12.7%Q4 2021
MRKMerck & Co., Inc.$3.85M0.71%0.00%-43.2%Q4 2021
WVEWave Life Sciences, Inc.$3.28M0.60%0.10%+13.5%Q3 2024
ENGNenGene Therapeutics Inc.$3.18M0.59%0.53%NewQ4 2025
BNTXBioNTech SE$3.17M0.58%0.01%+75.3%Q2 2025
KRYSKrystal Biotech, Inc.$3M0.55%0.04%Not reportedQ1 2022
ABEVAmbev S.A.$2.63M0.48%0.01%+18.5%Q1 2022
ZLABZai Lab Ltd$2.33M0.43%0.01%Not reportedQ4 2021
CRSPCRISPR Therapeutics AG$2.25M0.41%0.04%+7.2%Q1 2022
BEAMBeam Therapeutics Inc.$1.98M0.36%0.07%+17.2%Q3 2025
LXEOLexeo Therapeutics, Inc.$1.91M0.35%0.26%+0.1%Q4 2024
STOKStoke Therapeutics, Inc.$1.75M0.32%0.09%NewQ4 2025
MGTXMeiraGTx Holdings plc$1.59M0.29%0.25%+22.7%Q1 2024
FDMT4D Molecular Therapeutics, Inc.$1.58M0.29%0.36%+6.4%Q3 2023
SLBSLB Limited$1.49M0.27%0.00%+97.0%Q4 2021
MRNAModerna, Inc.$1.46M0.27%0.01%+5.5%Q1 2022
HIMSHims & Hers Health, Inc.$1.3M0.24%Not reportedNot reportedQ2 2025
RNACCartesian Therapeutics, Inc.$1.24M0.23%0.66%NewQ4 2025
VZLAVizsla Silver Corp.$1.12M0.21%0.07%Not reportedQ3 2024
PFEPfizer Inc$940K0.17%0.00%Not reportedQ1 2023
SRPTSarepta Therapeutics, Inc.$925K0.17%0.04%Not reportedQ2 2025
TSHATaysha Gene Therapies, Inc.$907K0.17%0.06%+22.2%Q2 2024
NOVNOV Inc.$830K0.15%0.01%-16.8%Q4 2021
SASeabridge Gold Inc$703K0.13%0.03%-51.0%Q3 2022
AUTLAutolus Therapeutics plc$649K0.12%0.12%+5.6%Q1 2022
RCKTRocket Pharmaceuticals, Inc.$597K0.11%0.16%-60.7%Q2 2022
RIGTransocean Ltd.$577K0.11%0.01%+36.9%Q3 2025
SDSandridge Energy Inc$560K0.10%0.11%-23.0%Q2 2024
Q3 2025Reported Nov 4, 202558 positions
TSLATesla, Inc.$109M19.51%0.01%+0.8%Q2 2022
SPOTSpotify Technology S.A.$66.3M11.92%0.05%-16.7%Q4 2021
SHOPShopify Inc.$61.7M11.09%0.11%-3.5%Q4 2021
PLTRPalantir Technologies Inc.$36.5M6.56%0.01%-42.9%Q4 2021
AMZNAmazon Com Inc$32.7M5.88%0.00%Not reportedQ3 2022
SESea Ltd$28.6M5.14%0.09%-23.8%Q4 2021
COINCoinbase Global, Inc.$26.7M4.79%0.03%+12.9%Q4 2021
QUREuniQure N.V.$22.5M4.05%0.62%-13.7%Q4 2021
ARWRArrowhead Pharmaceuticals, Inc.$16.3M2.94%0.35%-22.6%Q4 2021
IONSIonis Pharmaceuticals Inc$16.3M2.93%0.15%-7.0%Q4 2021
NVDANvidia Corp$15.1M2.72%0.00%Not reportedQ2 2022
PRQRProQR Therapeutics N.V.$10.6M1.91%4.75%0.0%Q4 2021
AMDAdvanced Micro Devices Inc$9.71M1.75%0.00%Not reportedQ3 2022
RAREUltragenyx Pharmaceutical Inc.$8.72M1.57%0.30%+14.4%Q4 2021
LMNDLemonade, Inc.$7.76M1.40%0.19%Not reportedQ1 2023
BIIBBiogen Inc.$7.27M1.31%0.04%+153.3%Q1 2022
AXSMAxsome Therapeutics, Inc.$6.4M1.15%0.10%Not reportedQ1 2023
IRENIREN Ltd$6.1M1.10%Not reportedNewQ3 2025
ARQTArcutis Biotherapeutics, Inc.$5.77M1.04%0.25%-11.2%Q4 2024
MRKMerck & Co., Inc.$5.4M0.97%0.00%+9.0%Q4 2021
ASTSAST SpaceMobile, Inc.$5.4M0.97%Not reportedNot reportedQ3 2024
ZLABZai Lab Ltd$4.48M0.81%0.01%Not reportedQ4 2021
URGNUroGen Pharma Ltd.$3.92M0.71%0.42%+82.7%Q4 2024
VRTXVertex Pharmaceuticals Inc / Ma$3.25M0.58%0.00%Not reportedQ4 2021
CRSPCRISPR Therapeutics AG$2.59M0.47%0.04%-10.5%Q1 2022
ABVXAbivax S.A.$2.58M0.46%0.05%NewQ3 2025
RNAMAvidity Biosciences, Inc.$2.31M0.42%0.04%+15.2%Q1 2024
HIMSHims & Hers Health, Inc.$2.27M0.41%Not reported+81.8%Q2 2025
KRYSKrystal Biotech, Inc.$2.15M0.39%0.04%+30.6%Q1 2022
ABEVAmbev S.A.$2M0.36%0.01%+12.7%Q1 2022
ROIVRoivant Sciences Ltd.$1.92M0.35%0.02%Not reportedQ4 2023
BNTXBioNTech SE$1.87M0.34%0.01%+72.9%Q2 2025
FDMT4D Molecular Therapeutics, Inc.$1.72M0.31%0.42%Not reportedQ3 2023
ACADAcadia Pharmaceuticals Inc$1.5M0.27%0.04%-52.6%Q1 2024
BEAMBeam Therapeutics Inc.$1.48M0.27%0.06%NewQ3 2025
RCKTRocket Pharmaceuticals, Inc.$1.41M0.25%0.40%Not reportedQ2 2022
MGTXMeiraGTx Holdings plc$1.34M0.24%0.20%Not reportedQ1 2024
LXEOLexeo Therapeutics, Inc.$1.28M0.23%0.35%+7.9%Q4 2024
WVEWave Life Sciences, Inc.$1.24M0.22%0.11%+25.4%Q3 2024
MRNAModerna, Inc.$1.21M0.22%0.01%-54.6%Q1 2022
SASeabridge Gold Inc$1.17M0.21%0.05%+10.0%Q3 2022
PFEPfizer Inc$962K0.17%0.00%+2.0%Q1 2023
ALXOAlx Oncology Holdings Inc$932K0.17%0.95%Not reportedQ2 2024
VZLAVizsla Silver Corp.$884K0.16%0.07%-18.4%Q3 2024
NOVNOV Inc.$846K0.15%0.02%Not reportedQ4 2021
PAASPan American Silver Corp$718K0.13%0.01%-37.7%Q3 2022
SLBSLB Limited$677K0.12%0.00%Not reportedQ4 2021
RXRXRecursion Pharmaceuticals, Inc.$581K0.10%0.02%Not reportedQ2 2024
SDSandridge Energy Inc$568K0.10%0.14%+36.1%Q2 2024
AUTLAutolus Therapeutics plc$503K0.09%0.12%+5.0%Q1 2022
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.